198 related articles for article (PubMed ID: 23077212)
1. The Birt-Hogg-Dubé tumor suppressor Folliculin negatively regulates ribosomal RNA synthesis.
Gaur K; Li J; Wang D; Dutta P; Yan SJ; Tsurumi A; Land H; Wu G; Li WX
Hum Mol Genet; 2013 Jan; 22(2):284-99. PubMed ID: 23077212
[TBL] [Abstract][Full Text] [Related]
2. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
[TBL] [Abstract][Full Text] [Related]
3. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.
Baba M; Keller JR; Sun HW; Resch W; Kuchen S; Suh HC; Hasumi H; Hasumi Y; Kieffer-Kwon KR; Gonzalez CG; Hughes RM; Klein ME; Oh HF; Bible P; Southon E; Tessarollo L; Schmidt LS; Linehan WM; Casellas R
Blood; 2012 Aug; 120(6):1254-61. PubMed ID: 22709692
[TBL] [Abstract][Full Text] [Related]
4. Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.
Clausen L; Stein A; Grønbæk-Thygesen M; Nygaard L; Søltoft CL; Nielsen SV; Lisby M; Ravid T; Lindorff-Larsen K; Hartmann-Petersen R
PLoS Genet; 2020 Nov; 16(11):e1009187. PubMed ID: 33137092
[TBL] [Abstract][Full Text] [Related]
5. Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculin.
Tee AR; Pause A
Fam Cancer; 2013 Sep; 12(3):367-72. PubMed ID: 23096221
[TBL] [Abstract][Full Text] [Related]
6. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
7. Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression.
Nagashima K; Fukushima H; Shimizu K; Yamada A; Hidaka M; Hasumi H; Ikebe T; Fukumoto S; Okabe K; Inuzuka H
Oncotarget; 2017 Feb; 8(6):9947-9960. PubMed ID: 28039480
[TBL] [Abstract][Full Text] [Related]
8. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.
Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A
J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504
[TBL] [Abstract][Full Text] [Related]
9. Birt-Hogg-Dube syndrome is a novel ciliopathy.
Luijten MN; Basten SG; Claessens T; Vernooij M; Scott CL; Janssen R; Easton JA; Kamps MA; Vreeburg M; Broers JL; van Geel M; Menko FH; Harbottle RP; Nookala RK; Tee AR; Land SC; Giles RH; Coull BJ; van Steensel MA
Hum Mol Genet; 2013 Nov; 22(21):4383-97. PubMed ID: 23784378
[TBL] [Abstract][Full Text] [Related]
10. A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic.
Enomoto Y; Namba Y; Hoshika Y; Komemushi Y; Mitani K; Kume H; Kobayashi E; Miyama Y; Homma Y; Ushiku T; Seyama K
Eur J Med Genet; 2020 Apr; 63(4):103820. PubMed ID: 31778855
[TBL] [Abstract][Full Text] [Related]
11. FLCN regulates transferrin receptor 1 transport and iron homeostasis.
Wang X; Wu H; Zhao L; Liu Z; Qi M; Jin Y; Liu W
J Biol Chem; 2021; 296():100426. PubMed ID: 33609526
[TBL] [Abstract][Full Text] [Related]
12. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
Hasumi H; Baba M; Hasumi Y; Lang M; Huang Y; Oh HF; Matsuo M; Merino MJ; Yao M; Ito Y; Furuya M; Iribe Y; Kodama T; Southon E; Tessarollo L; Nagashima K; Haines DC; Linehan WM; Schmidt LS
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1624-31. PubMed ID: 25775561
[TBL] [Abstract][Full Text] [Related]
13. Birt-Hogg-Dube syndrome: clinicopathological features of the lung.
Furuya M; Nakatani Y
J Clin Pathol; 2013 Mar; 66(3):178-86. PubMed ID: 23223565
[TBL] [Abstract][Full Text] [Related]
14. A Case of Birt-Hogg-Dubé (BHD) Syndrome Harboring a Novel Folliculin (FLCN) Gene Mutation.
Yukawa T; Fukazawa T; Yoshida M; Morita I; Kato K; Monobe Y; Furuya M; Naomoto Y
Am J Case Rep; 2016 Oct; 17():788-792. PubMed ID: 27780965
[TBL] [Abstract][Full Text] [Related]
15. Splice-site mutation causing partial retention of intron in the FLCN gene in Birt-Hogg-Dubé syndrome: a case report.
Furuya M; Kobayashi H; Baba M; Ito T; Tanaka R; Nakatani Y
BMC Med Genomics; 2018 May; 11(1):42. PubMed ID: 29720200
[TBL] [Abstract][Full Text] [Related]
16. Genetic characterization of the Drosophila birt-hogg-dubé syndrome gene.
Liu W; Chen Z; Ma Y; Wu X; Jin Y; Hou S
PLoS One; 2013; 8(6):e65869. PubMed ID: 23799055
[TBL] [Abstract][Full Text] [Related]
17. Loss of the Birt-Hogg-Dubé gene product folliculin induces longevity in a hypoxia-inducible factor-dependent manner.
Gharbi H; Fabretti F; Bharill P; Rinschen MM; Brinkkötter S; Frommolt P; Burst V; Schermer B; Benzing T; Müller RU
Aging Cell; 2013 Aug; 12(4):593-603. PubMed ID: 23566034
[TBL] [Abstract][Full Text] [Related]
18. Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility.
Preston RS; Philp A; Claessens T; Gijezen L; Dydensborg AB; Dunlop EA; Harper KT; Brinkhuizen T; Menko FH; Davies DM; Land SC; Pause A; Baar K; van Steensel MA; Tee AR
Oncogene; 2011 Mar; 30(10):1159-73. PubMed ID: 21057536
[TBL] [Abstract][Full Text] [Related]
19. Birt Hogg-Dubé syndrome-associated FLCN mutations disrupt protein stability.
Nahorski MS; Reiman A; Lim DH; Nookala RK; Seabra L; Lu X; Fenton J; Boora U; Nordenskjöld M; Latif F; Hurst LD; Maher ER
Hum Mutat; 2011 Aug; 32(8):921-9. PubMed ID: 21538689
[TBL] [Abstract][Full Text] [Related]
20. Loss of FLCN inhibits canonical WNT signaling via TFE3.
Kennedy JC; Khabibullin D; Hougard T; Nijmeh J; Shi W; Henske EP
Hum Mol Genet; 2019 Oct; 28(19):3270-3281. PubMed ID: 31272105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
